Cargando…

Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports

BACKGROUND: Histologic grade of ductal carcinoma in situ of the breast (DCIS) may become the single biomarker that decides whether patients will be treated. Yet, evidence shows that grading variation in daily practice is substantial. To facilitate quality improvement, feedback reports, in which labo...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dooijeweert, Carmen, van Diest, Paul J., Baas, Inge O., van der Wall, Elsken, Deckers, Ivette A. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216330/ https://www.ncbi.nlm.nih.gov/pubmed/32393303 http://dx.doi.org/10.1186/s13000-020-00970-8

Ejemplares similares

Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands
por: van Dooijeweert, Carmen, et al.
Publicado: (2019)

Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands
por: van Dooijeweert, Carmen, et al.
Publicado: (2018)

Significant inter‐ and intra‐laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands
por: van Dooijeweert, Carmen, et al.
Publicado: (2019)

The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients
por: van Dooijeweert, C., et al.
Publicado: (2021)

Variability in grading of ductal carcinoma in situ among an international group of pathologists
por: van Seijen, Maartje, et al.
Publicado: (2021)

Ductal Carcinoma In Situ: What the Pathologist Needs to Know and Why
por: Bane, Anita
Publicado: (2013)

Grading of invasive breast carcinoma: the way forward
por: van Dooijeweert, C., et al.
Publicado: (2021)

Significant Inter- and Intralaboratory Variation in Gleason Grading of Prostate Cancer: A Nationwide Study of 35,258 Patients in The Netherlands
por: Flach, Rachel N., et al.
Publicado: (2021)

Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study
por: Vermeulen, Jeroen F., et al.
Publicado: (2012)

HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers
por: van der Groep, Petra, et al.
Publicado: (2013)

Deep learning-based grading of ductal carcinoma in situ in breast histopathology images
por: Wetstein, Suzanne C., et al.
Publicado: (2021)

Time Trends in Histopathological Findings in Mammaplasty Specimens in a Dutch Academic Pathology Laboratory
por: Stutterheim, Hannah W., et al.
Publicado: (2023)

Review by urological pathologists improves the accuracy of Gleason grading by general pathologists
por: Nakai, Yasushi, et al.
Publicado: (2015)

Pathology of hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2011)

Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile
por: Suelmann, B. B. M., et al.
Publicado: (2021)

Comparative Evaluation of Breast Ductal Carcinoma Grading: A Deep-Learning Model and General Pathologists’ Assessment Approach
por: Köteles, Maria Magdalena, et al.
Publicado: (2023)

Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast
por: Kuijper, Arno, et al.
Publicado: (2005)

Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression
por: Hyseni, Agon, et al.
Publicado: (2011)

Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast
por: Perez, Amanda Arantes, et al.
Publicado: (2013)

Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists
por: Bulten, Wouter, et al.
Publicado: (2020)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer
por: Suelmann, B. B. M., et al.
Publicado: (2022)

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer
por: Moelans, Cathy B., et al.
Publicado: (2018)

Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer
por: Vermeulen, Jeroen F., et al.
Publicado: (2012)

Prognostic Value of Mitotic Index and Bcl2 Expression in Male Breast Cancer
por: Lacle, Miangela M., et al.
Publicado: (2013)

Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer
por: Vermeulen, Jeroen F., et al.
Publicado: (2013)

Nationwide differences in cytology fixation and processing methods and their impact on interlaboratory variation in PD-L1 positivity
por: Koomen, Bregje M., et al.
Publicado: (2022)

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004)

Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast
por: Gomes, Douglas S, et al.
Publicado: (2014)

Expression of Connective Tissue Growth Factor in Male Breast Cancer: Clinicopathologic Correlations and Prognostic Value
por: Lacle, Miangela M., et al.
Publicado: (2015)

Comparison of Different Promoter Methylation Assays in Breast Cancer
por: Suijkerbuijk, Karijn P. M., et al.
Publicado: (2010)

Conditional Inactivation of HIF-1 Using Intrabodies
por: Groot, Arjan J., et al.
Publicado: (2008)

The predictive value of calcification for the grading of ductal carcinoma in situ in Chinese patients
por: Kong, Jianchun, et al.
Publicado: (2020)

Correction to Lancet Gastroenterol Hepatol 2019; 4: 934–47
Publicado: (2020)

Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management
por: Moelans, Cathy B, et al.
Publicado: (2019)

Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
por: van Voss, Marise R Heerma, et al.
Publicado: (2010)

Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
por: Heerma van Voss, Marise R., et al.
Publicado: (2011)

Classification of follicular lymphoma: the effect of computer aid on pathologists grading
por: Fauzi, Mohammad Faizal Ahmad, et al.
Publicado: (2015)

Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians
por: Gasparrini, Silvia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cl2rvful7k0d3ea14agaea51rj